Paul Bisaro, Director at TherapeuticsMD, Inc. (TXMD), bought 50,000 shares at $0.79 ($40K) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Open-market purchase of $40k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| MNK | BUY | 2023-03-16 | $42K | — | Filing → |
| TXMD | BUY | 2020-06-08 | $114K | — | Filing → |
| AMRX | BUY | 2019-03-12 | $203K | — | Filing → |